KS SB236 | 2023-2024 | Regular Session
Status
Spectrum: Committee Bill
Status: Introduced on February 10 2023 - 25% progression
Action: 2023-02-13 - Senate Referred to Committee on Financial Institutions and Insurance
Pending: Senate Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 10 2023 - 25% progression
Action: 2023-02-13 - Senate Referred to Committee on Financial Institutions and Insurance
Pending: Senate Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.
Title
Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-02-13 | Senate | Senate Referred to Committee on Financial Institutions and Insurance |
| 2023-02-10 | Senate | Senate Introduced |
